Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 12,840 shares at $18.30 ($236K) on 2025-05-07, disclosed to the SEC on 2025-05-09.
Scheduled sale ($236k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.30 | 6,173 | $113K | 48.0% |
| 2 | $18.30 | 6,173 | $113K | 48.0% |
| 3 | $19.40 | 390 | $8K | 3.2% |
| 4 | $19.87 | 104 | $2K | 0.9% |
| Total | $18.35 avg | 12,840 | $236K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |